Introduction/Background Laparoscopic para-aortic lymphadenectomy(PAL) was described first in 1992 by Nezhat and in 1993 by the group of Querleu, in cases of endometrial, cervical and ovarian cancer.

Likewise, in 1993, JM.Childers and his group developed a transperitoneal technique with a lateral approach that allows greater ergonomics for both the surgeon and assistants, with oncological results comparable to the classic technique.

A video of a PAL using the Childers-technique is presented, which is the usual technique used by our group.

Methodology Description of the Childers PAL using video, on a 50-year-old woman with a high grade cervical adenocarcinoma FIGO-IIIC1.

Results Step-by-step technique: Right side.

The surgen is on the left side of the patient:

• GENTLY PLACE ALL POSSIBLE LOOPS OF SMALL INTESTINE UP TO THE MESENTERY UNDER THE RIGHT HEPATIC LOBE.

• LOCATE DUODENUM AND AORTIC BIFURCATION.

• PERITONEUM OPENING OVER AORTA.

• LOCATE THE RIGHT URETER AND PULL IT VENTRALLY.

• LATERAL DISSECTION UP TO OVARIAN VEIN ARCH AND ITS LIGATION.

• CAUDAL DISSECTION UNTIL RIGHT COMMON ILIAC BIFURCATION.

• OPENING OF ADVENTITIAL PLANE OVER AORTA.

• LYMPHATIC DISSECTION BY VENTRAL TRACTION OF LYMPHATIC TISSUE UNTIL REACHING THE CAVE.

• COMPLETE THE LYMPHADENECTOMY.

Left side.

The surgen on the right side of the patient. :

• OPENING OF ADVENTITIAL PLANE FIRST ON THIS SIDE.

• LOCATION OF THE URETER.

• DISSECTION OF LYMPHATIC PACKAGE ON AORTA.

• SUPERIOR MESENTERIC ARTERY DISSECTION.

• OPENING OF PERITONEUM TO RENAL VEIN AS UPPER LIMIT.

• CONTINUE WITH SUPRAMESENTERIC DISSECTION UNTIL THE RENAL VEIN.

• COMPLETE THE LYMPHADENECTOMY GENTLY ON THE RENAL VEIN.

• INTERILIAC LYMPHADENECTOMY.

Conclusion Childers-PLA is a technique comparable in oncological results to the classic technique, with advantages in ergonomics for the surgeon and reproducibility of the technique. The disadvantages are those of the transperitoneal technique and the need in many cases for a second assistant to complete the approach to the supramesenteric region.

Disclosures No disclosures.